Abilify®(Aripiprazole)
Remarks: The information provided by this website can only serve as reference. Only your physician can provide you the most suitable therapy and medical follow ups.
Aripiprazole is a new generation of atypical antipsychotics. Its pharmacological effects are believed to arise primarily through partial agonism at dopamine D2/serotonin 5HT1A receptors, and antagonism at serotonin 5HT2A receptors. It is available in 10mg and 15mg tablets.
Indication:
- Schizophrenia
- Bipolar I disorder

According to the recent report from a medical journal (International Journal of Clinical Practice - IJCP) published in April, 2005 (Ref. 1), schizophrenia is a chronic disabling disease that often results in drastically impaired quality of life. The majority of patients with schizophrenia require long-term treatment with antipsychotics. The pharmacotherapy can be divided into typical (old version) and atypical (new version) drugs.

Before the development of atypical antipsychotics, treatment choice was restricted to conventional (or typical) antipsychotics, which are known to cause a range of side effects including extrapyramidal symptoms (EPS). Although atypical agents provide a favourable alternative (advocated by the National Institute of Clinical Excellence in the UK) because of the lower incidence of EPS, they are still associated with side effects such as weight gain, sedation and hyperprolactinaemia.

The Schizophrenia Innovation Working Group of the medical report (IJCP) suggested that compared with available antipsychotics, Aripiprazole may offer a useful alternative for patients for whom weight gain, EPS and sedation are barriers to long term treatment.
 
Further information:
 

www.abilify.com
   

Ref. 1：Int J Clin Pract,April 2005,59(4)485-495
Pletaal®(Cilostazol)
Remarks: The information provided by this website can only serve as reference. Only your physician can provide you the most suitable therapy and medical follow ups.

Cilostazol is a phosphodiesterase III inhibitor. It increases cAMP in platelets and vascular smooth muscle cells. Therefore, it has antiplatelet and vasodilatation effects. It is supplied as 50mg tablets.

Indication:
-

Treatment of ischemic symptoms, including ulceration, pain, and coldness of the extremities, in chronic arterial occlusion.
- Prevention of recurrence of cerebral infarction (excluding cardiogenic cerebral embolism)
Meptin®(Carteolol hydrochloride)
Remarks: The information provided by this website can only serve as reference. Only your physician can provide you the most suitable therapy and medical follow ups.

Procaterol hydrochloride is a bronchodilator. It is supplied in 3 different forms: tablet (25mcg, 50mcg), syrup (5mcg/ml x 60ml, 450ml) and aerosol (10mcg/puff x 200 puffs)

Indication:
-

Meptin is recommended for the relief of dyspnoea and other symptoms caused by the following airway obstruction: bronchial asthma, chronic bronchitis and pulmonary emphysema.
Arteoptic®(Procaterol hydrochloride)
Remarks: The information provided by this website can only serve as reference. Only your physician can provide you the most suitable therapy and medical follow ups.

Carteolol hydrochloride is a β-blocker. It is supplied as eye-drops (1% and 2%).

Indication:
- Glaucoma
- Ocular Hypertension
Aminoleban® EN
Remarks: The information provided by this website can only serve as reference. Only your physician can provide you the most suitable therapy and medical follow ups.

Aminoleban® EN is an enriched complete oral formula for liver cirrhotic patients. It contains high content 41% branched chain amino acid in total proteins with essential micro-nutrients including vitamins A, D, E and K and zinc which are commonly deficient in liver disease patients. Other ingredients include carbohydrate, fat, vitamins, minerals and trace elements. Therefore, Aminoleban® EN can improve the imbalance of amino acid levels and Fischer's Ratio caused by the liver disease.

Clinical benefits
-

Corrects plasma amino acids imbalance (Ref. 1 & 2)

- Improve liver function (Ref. 1, 2, 3 & 4)
(e.g. increase in serum albumin level and decrease in bilirubin)
- Reduces the incidence rates of ascites and peripheral oedema (Ref. 4)
- Reduces hospital re-admission rates/shortens hospital stay (Ref. 3 & 4)
- Improves quality of life/performance status in patients (Ref. 1, 2 & 4)
   
 
Indication:
-

Improvement of the nutritional state of chronic liver-failure patients accompanied with hepatic encephalopathy

 
Dosage:
-

Reconstitute one package (50g) of Aminoleban®EN in about 180ml of slightly warm water (about 200Kcal/200ml) and takes three times a day. The dosage should be determined by patient's age and condition, judged by physicians.

Aminoleban is also supplied in intravenous solution. It is used to treat hepatic coma because of liver cirrhosis or acute & chronic liver diseases. It can also be served as a nutritional supplement for liver patients who are strictly advised not to eat.

 
Ref. 1: The San-In Group of Liver Surgery: British Journal of Surgery , 1997; 84:1525-1531
Ref. 2: Ichida T., et al: Nutrition, 1995; 11:238-244
Ref. 3: Meng W.C.S., et al: Aust. N.Z.J. Surg., 1999; 69:811-815
Ref. 4: Poon R.T.P., et al : Aliment Pharmacol Ther 2004; 19:779-788
Futraful® (Tegafur)
Remarks: The information provided by this website can only serve as reference. Only your physician can provide you the most suitable therapy and medical follow ups.
 

Tegafur is a chemotherapeutic agent and belongs to the group of oncology medication. It is supplied as 200mg capsules.

Indication:
-

Remission of subjective and objective symptoms in gastrointestinal (gastric and colorectal cancers) and breast cancers

Intravenous(I.V.) solutions
Remarks: The information provided by this website can only serve as reference. Only your physician can provide you the most suitable therapy and medical follow ups.
 
 
     
 
Terms of Use
Sitemap
Copyright 2007 Otsuka Pharmaceutical (H.K.) Ltd.